Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Equities researchers at William Blair issued their Q2 2017 earnings per share estimates for shares of Acadia Healthcare in a note issued to investors on Tuesday. William Blair analyst R. Daniels expects that the company will post earnings of $0.64 per share for the quarter. William Blair has a “Outperform” rating on the stock. William Blair also issued estimates for Acadia Healthcare’s Q3 2017 earnings at $0.67 EPS, Q4 2017 earnings at $0.67 EPS, FY2017 earnings at $2.44 EPS, FY2018 earnings at $2.82 EPS and FY2019 earnings at $3.11 EPS.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Tuesday, April 25th. The company reported $0.46 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.46. Acadia Healthcare had a return on equity of 8.89% and a net margin of 0.53%. The business had revenue of $679.20 million for the quarter, compared to analysts’ expectations of $691.74 million. During the same quarter in the previous year, the firm earned $0.55 earnings per share. The business’s revenue was up 10.1% compared to the same quarter last year.

WARNING: “Acadia Healthcare Company, Inc. Expected to Post Q2 2017 Earnings of $0.64 Per Share (NASDAQ:ACHC)” was posted by American Banking News and is the property of of American Banking News. If you are reading this report on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/07/20/acadia-healthcare-company-inc-expected-to-post-q2-2017-earnings-of-0-64-per-share-nasdaqachc.html.

A number of other equities research analysts have also issued reports on ACHC. BidaskClub upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, June 10th. Zacks Investment Research upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and set a $53.00 target price on the stock in a research note on Wednesday, June 28th. Cantor Fitzgerald restated a “hold” rating and issued a $45.00 target price on shares of Acadia Healthcare in a research note on Wednesday, April 26th. Jefferies Group LLC restated a “buy” rating on shares of Acadia Healthcare in a research note on Monday, May 15th. Finally, KeyCorp restated an “overweight” rating and issued a $51.00 target price on shares of Acadia Healthcare in a research note on Thursday, June 1st. Three equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $57.23.

Shares of Acadia Healthcare (NASDAQ:ACHC) opened at 50.43 on Thursday. The firm has a market cap of $4.43 billion, a PE ratio of 293.20 and a beta of 1.14. The stock’s 50 day moving average price is $46.96 and its 200-day moving average price is $43.05. Acadia Healthcare has a 52-week low of $32.54 and a 52-week high of $57.29.

In other Acadia Healthcare news, COO Ronald Morgan Fincher sold 86,483 shares of the company’s stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $44.43, for a total value of $3,842,439.69. Following the completion of the transaction, the chief operating officer now owns 137,204 shares in the company, valued at approximately $6,095,973.72. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Reeve B. Waud sold 724,694 shares of the company’s stock in a transaction dated Wednesday, June 14th. The stock was sold at an average price of $45.53, for a total transaction of $32,995,317.82. The disclosure for this sale can be found here. In the last quarter, insiders have sold 968,102 shares of company stock worth $44,283,109. 11.10% of the stock is owned by company insiders.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Emerald Mutual Fund Advisers Trust purchased a new position in Acadia Healthcare during the first quarter valued at approximately $210,000. Paloma Partners Management Co purchased a new position in Acadia Healthcare during the first quarter valued at approximately $217,000. M&T Bank Corp purchased a new position in Acadia Healthcare during the first quarter valued at approximately $230,000. Teacher Retirement System of Texas purchased a new position in Acadia Healthcare during the first quarter valued at approximately $258,000. Finally, Benjamin F. Edwards & Company Inc. boosted its position in Acadia Healthcare by 224.2% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 6,290 shares of the company’s stock valued at $274,000 after buying an additional 4,350 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.